ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

PHGN Pharming Group NV

0,837
-0,0155 (-1,82%)
17:16:03 - Echtzeitdaten
Name Symbol Markt Aktientyp
Pharming Group NV PHGN Tradegate Ordinary Share
  Änderung Änderung % Aktuell Zeit
-0,0155 -1,82% 0,837 17:16:03
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,8605 0,836 0,8605 0,8525
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
20.5.202408:00GLOBEPharming Group to participate in May investor conference
15.5.202407:00GLOBEPharming Group announces the early redemption of the..
08.5.202407:00GLOBEPharming Group reports first quarter 2024 financial results..
24.4.202408:00GLOBEPharming Group to report first quarter 2024 financial..
24.4.202407:00GLOBEPharming to be honored as Industry Innovator at National ..
19.4.202418:43GLOBEPharming Group announces the repurchase of outstanding €125..
18.4.202415:04GLOBEPharming Group announces the placement of €100 million..
18.4.202408:00GLOBEPharming Group announces the launch of an offering of..
08.4.202407:00GLOBEPharming announces completion of enrollment in pediatric..
04.4.202408:30GLOBEPharming Group announces the 2024 Annual General Meeting of..
04.4.202407:00GLOBEPharming Group announces the filing of its 2023 Annual..
03.4.202408:00GLOBEPharming Group to participate in April investor conferences
14.3.202407:00GLOBEPharming Group reports fourth quarter and full year 2023..
29.2.202408:00GLOBEPharming Group to report fourth quarter and full year 2023..
08.2.202408:00GLOBEPharming Group to participate in February investor..
08.1.202407:00GLOBEPharming Group announces updated full year 2023 guidance and..
13.12.202307:00GLOBEPharming Group announces development plans for leniolisib..
21.11.202307:00GLOBEPharming announces first patient dosed in pediatric clinical..
10.11.202314:51GLOBEPharming Group provides updates on EMA regulatory review of..
01.11.202308:00GLOBEPharming Group to participate in November investor..
26.10.202307:00GLOBEPharming Group reports third quarter 2023 financial results
12.10.202308:00GLOBEPharming Group to report third quarter 2023 financial..
25.9.202316:00GLOBEPharming Group reports on results of the 2023 Extraordinary..